Your Subtitle text

A Summary of news specifically related to Lung Cancer

December 6, 2013 by medical news today
Therapeutic benefits of Carbon Monoxide for prostate, Lung Cancer
Now as study led by a research team at Beth Israel Deaconess Medical Center shows for the first time that carbon monoxide may also have a role to play in treating cancer.

November 22, 2013
A Leading driver of Cancer Blocked
The protein in cells that most often drives the development of cancers has eluded scientists' efforts to block it for three decades - until now.

September 27, 2013
Could Antidepressant Combat Lethal Lung Cancer?
Using a unique computer program, researchers from the Stanford University School of Medicine identified tricyclic antidepressants as a potential treatment for small cell lung cancer. Follow-up experiments showed that the tricyclic antidepressant called imipramine (Tofranil), was effective against human small cell lung cancer cells grown in the laboratory and growing as tumors in mice. The drug activated a self-destruction pathway in the cancer cells and slowed or blocked the spread of cancer in mice.

September 17, 2013
New marker identified for early diagnosis of lung cancer
A protein called isocitrate dehydrogenase (IDH1) is present at high levels in lung cancers and can be detected in the blood, making it a noninvasive diagnostic marker for lung cancers, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

June 5, 2013
Immune Therapy Active Against NSCLC
One of the entrants in a new class of cancer immunotherapies had promising activity and safety against non-small cell lung cancer.

May 16, 2013
Test Approved to Detect Faulty Lung Cancer Gene
The U.S. Food and Drug Administration has approved a test designed to detect a faulty gene that's present in about 10 percent of cases of non-small cell lung cancer (NSCLC).

January 3, 2013
President Obama Signs High Mortality Cancer Bill Into Law
Just hours before the end of the 112th Congress, constitutional deadline for approval of a bill previously passed by Congress, President Barack Obama today signed into law the first legislation requiring comprehensive plans of research action for high mortality cancers, with lung and pancreatic cancers given priority status for expedited attention. This landmark legislation, included in the National Defense Authorization Act of 2013, requires the National Cancer Institute (NCI) to develop scientific frameworks for addressing cancers with survival rates of less than 50%, with first priority attention to lung and pancreatic cancers.

December 21, 2012
Congress Gives Its Final Approval to Lung Cancer Research Bill
Only the President Signature Needed to Become Law
Today, the Senate gave its final approval to legislation containing the Recalcitrant Cancer Research Act that gives priority status to lung and pancreatic cancers for the development of a master plan of action that the National Cancer Institute must send to Congress and make publicly available within 18 months. The President is expected to sign the bill, the Defense Authorization Act for Fiscal Year 2013, which contains the cancer legislation.

April 3, 2012
New antibody offers broad cancer treatment, "From the Stanford Daily"
Researchers from the Stanford School of Medicine have developed an antibody shown to be effective in treating a wide range of cancers. The antibody encourages the body’s immune system to attack cancerous cells and could help treat patients with advanced cases of the disease.

June 2012
Lung Cancer Deaths Rise Among 'Boomer' Women in the South

August 3, 2007
Senate Reiterates Calls For Making Lung Cancer Research a National Priority.